12 hours 3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise MoveThe Motley Fool
When a company’s shares shoot up 82% in 12 months, investors clearly think it’s a good time to be a shareholder — and that’s exactly what’s happened to the stock of Madrigal Pharmaceuticals (NASDAQ: MDGL). Earlier this year, the up-and-coming biotech …
Biotech · Nasdaq 100 · Pharmaceuticals
X